Pacific Biosciences of California, Inc. Finite-Lived Intangible Asset, Expected Amortization, Year One
Pacific Biosciences of California, Inc. (PACB) had Finite-Lived Intangible Asset, Expected Amortization, Year One of $4.08 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths · last filed 2026-08-06
- 2026-06-30: Finite-Lived Intangible Asset, Expected Amortization, Year One $4.08M.
- 2026-03-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $4.08M.
- 2025-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $4.08M.
- 2025-09-30: Finite-Lived Intangible Asset, Expected Amortization, Year One $4.08M.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Year One |
|---|---|
| 2026-06-30 | $4.08M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $4.08M 10-Q · filed 2026-05-08 |
| 2025-12-31 | $4.08M 10-K · filed 2026-02-25 |
| 2025-09-30 | $4.08M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $4.08M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $4.08M 10-Q · filed 2025-05-12 |
| 2024-12-31 | $27.41M 10-K · filed 2025-03-17 |
| 2024-09-30 | $27.41M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $27.41M 10-Q · filed 2024-08-09 |
| 2024-03-31 | $27.41M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $27.41M 10-K · filed 2024-02-28 |
| 2023-09-30 | $27.41M 10-Q · filed 2023-11-03 |
| 2023-06-30 | $745.00K 10-Q · filed 2023-08-04 |
| 2023-03-31 | $745.00K 10-Q · filed 2023-05-04 |
| 2022-12-31 | $853.00K 10-K · filed 2023-02-28 |
| 2022-09-30 | $838.00K 10-Q · filed 2022-11-08 |
| 2022-06-30 | $838.00K 10-Q · filed 2022-08-08 |
| 2022-03-31 | $838.00K 10-Q · filed 2022-05-06 |
| 2021-12-31 | $913.00K 10-K · filed 2022-02-28 |
| 2021-09-30 | $913.00K 10-Q · filed 2021-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |